Very early researchLooking for participantsNCT04967833What this trial is testingGC101 TIL in Advanced Solid Tumors (TR)Who this might be right forAdvanced Solid Tumors Shanghai Juncell Therapeutics 20
Early research (Phase 1)UnknownNCT05393063What this trial is testingEvaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Akeso 36
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT02881138What this trial is testingRC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid TumorsWho this might be right forSolid Tumors RemeGen Co., Ltd. 24
Early research (Phase 1)Looking for participantsNCT06332755What this trial is testingStudy to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCWho this might be right forNon-small Cell Lung Cancer(NSCLC)Head and Neck Squamous Cell Carcinoma(HNSCC)Renal Cell Carcinoma(RCC)+2 more LG Chem 76
Early research (Phase 1)UnknownNCT02993913What this trial is testingSafety, Tolerability and Pharmacokinetics of Simmiparib in Patients With Malignant Advanced Solid TumorWho this might be right forMalignant Advanced Solid Tumor Shanghai Acebright Pharmaceuticals Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Early research (Phase 1)Looking for participantsNCT07262164What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Shanghai Virogin Biotech Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747What this trial is testingAvelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more M.D. Anderson Cancer Center 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT05951608What this trial is testingA Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Akeso 216
Early research (Phase 1)Study completedNCT01673737What this trial is testingA Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced CancerWho this might be right forNeoplasm Malignant Sanofi 75
Early research (Phase 1)Looking for participantsNCT03816345What this trial is testingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOWho this might be right forAutoimmune DiseaseCrohn DiseaseDermatomyositis+11 more National Cancer Institute (NCI) 300
Not applicableLooking for participantsNCT06075524What this trial is testingEvaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer TypesWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Lung Carcinoma+7 more Mayo Clinic 500
Testing effectiveness (Phase 2)Looking for participantsNCT07682870What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Virogin Biotech Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT07436728What this trial is testingTAK-505 in Adults With Solid TumorsWho this might be right forMalignant Solid Tumors Takeda 151
Early research (Phase 1)Not Yet RecruitingNCT07583914What this trial is testingSafety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid TumorsWho this might be right forSolid Tumor CancerMetastasesHead and Neck Cancer West China Hospital 9
Early research (Phase 1)Study completedNCT06372236What this trial is testingUTAA06 Injection for Treatment of Advanced Malignant Solid TumorsWho this might be right forConditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor Peking University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128What this trial is testingSelpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Who this might be right forNon-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more Eli Lilly and Company 857
Early research (Phase 1)Not Yet RecruitingNCT07644650What this trial is testingPhase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsWho this might be right forNeoplams Mabsoft Therapeutics (Shanghai) Co., Ltd. 420